DNA methylation changes in leukaemia

Seminars in Cancer Biology

Volumn 12, Issue 5, 2002, Pages 347-357

  Melki, John R ^a   Clark, Susan J ^a,b,c  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b University of Sydney   (Australia)

^c CSIRO   (Australia)

Author keywords

Cancer; DNA methyltransferase; Epigenetic; Leukaemia; Methylation

Indexed keywords

5 METHYLCYTOSINE; ACTIN; CALCITONIN; DNA METHYLTRANSFERASE; ESTROGEN RECEPTOR; PROTEIN P15; RETINOBLASTOMA PROTEIN; S ADENOSYLMETHIONINE; T LYMPHOCYTE RECEPTOR BETA CHAIN; UVOMORULIN;

ARTICLE; CANCER CELL; CHROMATIN; CPG ISLAND; DNA METHYLATION; ENZYME ACTIVITY; GENE MUTATION; GENE SILENCING; GENETIC TRANSCRIPTION; GENOTYPE; HUMAN; LEUKEMIA; LEUKEMOGENESIS; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

EID: 0036387011     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1044-579X(02)00055-X     Document Type: Article

References (83)

1. Baylin SB, Esteller M, Rountree MR, Bachman KE, Schuebel K, Herman JG (2001) Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. Hum Mol Genet 10:687-692
2. Holliday R (1990) DNA methylation and epigenetic inheritance. Philos Trans R Soc Lond B Biol Sci 326:329-338
3. Ferrucci L, Mezzanotte R, Vanni R, Stuppia R, Guanciali-Franchi P, Calabrese G, Palka G, Bianchi U, Sumner AT (1988) Effect of HpaII and MspI restriction endonucleases on chronic myelogenous leukemia chromosomes. Detection of CpG dinucleotide demethylation in situ. Cancer Genet Cytogenet 34:251-256
4. Bensaada M, Kiefer H, Tachdjian G, Lapierre LM, Cacheux V, Niveleau A, Metezeau P (1998) Altered patterns of DNA methylation on chromosomes from leukemia cell lines: identification of 5-methylcytosines by indirect immunodetection. Cancer Genet Cytogenet 103:101-109
5. El-Deiry WS, Nelkin BD, Celano P, Yen RW, Falco JP, Hamilton SR, Baylin SB (1991) High expression of the DNA methyltransferase gene characterizes human neoplastic cells and progression stages of colon cancer. Proc Natl Acad Sci USA 88: 3470-3474
6. Schmutte C, Yang AS, Nguyen TT, Beart RW, Jones PA (1996) Mechanisms for the involvement of DNA methylation in colon carcinogenesis. Cancer Res 56:2375-2381
7. Lee PJ, Washer LL, Law DJ, Boland CR, Horon IL, Feinberg AP (1996) Limited up-regulation of DNA methyltransferase in human colon cancer reflecting increased cell proliferation. Proc Natl Acad Sci USA 93:10366-10370
8. Issa JP, Vertino PM, Wu JJ, Sazawal S, Celano P, Nelkin BD, Hamilton SR, Baylin SB (1993) Increased cytosine DNA-methyltransferase activity during colon cancer progression. J Natl Cancer Inst 85:1235-1240
9. Belinsky SA, Nikula KJ, Baylin SB, Issa JP (1996) Increased cytosine DNA-methyltransferase activity is target-cell-specific and an early event in lung cancer. Proc Natl Acad Sci USA 93:4045-4050
10. Melki JR, Warnecke P, Vincent PC, Clark SJ (1998) Increased DNA methyltransferase expression in leukemia. Leukemia 12:311-316
11. Mizuno S, Chijiwa T, Okamura T, Akashi K, Fukumaki Y, Niho Y, Sasaki H (2001) Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia. Blood 97:1172-1179
12. Greenberg ML, Chanana AD, Cronkite EP, Giacomelli G, Schiffer LM, Stryctmans PA, Vincent PC (1972) The generation time of human leukemic myeloblasts. Lab Invest 26:245-252
13. Killmann SA (1965) Proliferative activity of blast cells in leukemia and myelofibrosis. Morphological differences between proliferating and non-proliferating blast cells. Acta Med Scand 178:263-280
14. Wu JJ, Issa JP, Herman JG, Bassett DE, Nelkin BD, Baylin SB (1993) Expression of an exogenous eukaryotic DNA methyltransferase gene induces transformation of NIH-3T3 cells. Proc Natl Acad Sci USA 90:8891-8895
15. Laird PW, Jackson-Grusby L, Fazeli A, Dickinson SL, Edward Jung W, Li E, Weinberg RA, Jaenisch R (1995) Suppression of intestinal neoplasia by DNA hypomethylation. Cell 81:197-205
16. Bandaru B, Gopal J, Bhagwat AS (1996) Overproduction of DNA cytosine methyltransferases causes methylation and C→T mutations at non-canonical sites. J Biol Chem 271:7851-7859
17. Rideout III WM, Coetzee GA, Olumi AF, Jones PA (1990) 5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes. Science 249:1288-1290
18. Gama-Sosa MA, Slagel VA, Trewyn RW, Oxenhandler R, Kuo KC, Gehrke CW, Ehrlich M (1983) The 5-methylcytosine content of DNA from human tumors. Nucleic Acids Res 11:6883-6894
19. Counts JL, Goodman JI (1995) Hypomethylation of DNA: a nongenotoxic mechanism involved in tumor promotion. Toxicol Lett 82/83:663-672
20. Cravo M, Pinto R, Fidalgo P, Chaves P, Gloria L, Nobreleitao C, Mira FC (1996) Global DNA hypomethylation occurs in the early stages of intestinal type gastric carcinoma. Gut 39:434-438
21. Wahlfors J, Hiltunen H, Heinonen K, Hamalainen E, Alhonen L, Jänne J (1992) Genomic hypomethylation in human chronic lymphocytic leukemia. Blood 80:2074-2080
22. Christman JK, Sheikhnejad G, Dizik M, Abileah S, Wainfan E (1993) Reversibility of changes in nucleic acid methylation and gene expression induced in rat liver by severe dietary methyl deficiency. Carcinogenesis 14:551-557
23. Pogribny IP, Basnakian AG, Miller BJ, Lopatina NG, Poirier LA, James SJ (1995) Breaks in genomic DNA and within the p53gene are associated with hypomethylation in livers of folate/methyl-deficient rats. Cancer Res 55:1894-1901
24. Pogribny IP, Miller BJ, James SJ (1997) Alterations in hepatic p53 gene methylation patterns during tumor progression with folate/methyl deficiency in the rat. Cancer Lett 115:31-38
25. Belinsky SA, Nikula KJ, Baylin SB, Issa JP (1995) A microassay for measuring cytosine DNA methyltransferase activity during tumor progression. Toxicol Lett 82/83:335-340
26. Adams RL, Rinaldi A, Seivwright C (1991) Microassay for DNA methyltransferase. J Biochem Biophys Methods 22:19-22
27. Fowler BM, Giuliano AR, Piyathilake C, Nour M, Hatch K (1998) Hypomethylation in cervical tissue: is there a correlation with folate status? Cancer Epidemiol Biomarkers Prev 7:901-906
28. Pfeifer GP, Steigerwald S, Boehm TL, Drahovsky D (1988) DNA methylation levels in acute human leukemia. Cancer Lett 39:185-192
29. Walsh CP, Chaillet JR, Bestor TH (1998) Transcription of IAP endogenous retroviruses is constrained by cytosine methylation. Nat Genet 20:116-117
30. Feinberg AP, Vogelstein B (1983) Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 301:89-92
31. Nakamura N, Takenaga K (1998) Hypomethylation of the metastasis-associated S100A4 gene correlates with gene activation in human colon adenocarcinoma cell lines. Clin Exp Metastasis 16:471-479
32. Nakayama M, Wada M, Harada T, Nagayama J, Kusaba H, Ohshima K, Kozuru M, Komatsu H, Ueda R, Kuwano M (1998) Hypomethylation status of CpG sites at the promoter region and overexpression of the human MDR1 gene in acute myeloid leukemias. Blood 92:4296-4307
33. Lengauer C, Kinzler KW, Vogelstein B (1997) DNA methylation and genetic instability in colorectal cancer cells. Proc Natl Acad Sci USA 94:2545-2550
34. Litz CE, Goldfarb AN, Strickler JG, Brunning RD (1990) Presence of cell lineage-specific hypomethylated sites in the major breakpoint cluster region. Cancer Res 50:4984-4990
35. Kawakubo K, Ohyashiki JH, Ohyashiki K, Tauchi T, Kimura N, Nakazawa S, Toyama K (1994) Hypomethylated status, but not RAG-1, is required for T-cell receptor-beta-chain gene rearrangement in acute leukemia cells. Cancer Genet Cytogenet 78:40-45
36. Ohyashiki JH, Ohyashiki K, Kawakubo K, Tauchi T, Nakazawa S, Kimura N, Toyama K (1992) T-cell receptor beta chain gene rearrangement in acute myeloid leukemia always occurs at the allele that contains the undermethylated J beta 1 region. Cancer Res 52:6598-6602
37. Wolffe AP, Jones PL, Wade PA (1999) DNA demethylation. Proc Natl Acad Sci USA 96:5894-5896
38. Miniou P, Bourchis D, Gomes DM, Jeanpierre M, Viegas-Pequignot E (1997) Undermethylation of Alu sequences in ICF syndrome: molecular and in situ analysis. Cytogenet Cell Genet 77:308-313
39. Ehrlich M, Buchanan KL, Tsien F, Jiang G, Sun B, Uicker W, Weemaes CM, Smeets D, Sperling K, Belohradsky BH et al. (2001) DNA methyltransferase 3B mutations linked to the ICF syndrome cause dysregulation of lymphogenesis genes. Hum Mol Genet 10:2917-2931
40. Kochanek S, Renz D, Doerfler W (1995) Transcriptional silencing of human alu sequences and inhibition of protein binding in the box b regulatory elements by 5′-CG-3′ methylation. FEBS Lett 360:115-120
41. Hellmann-Blumberg U, Hintz M, Gatewood JM, Schmid CW (1993) Developmental differences in methylation of human alu repeats. Mol Cell Biol 13:4523-4530
42. Englander EW, Wolffe AP, Howard BH (1993) Nucleosome interactions with a human alu element - transcriptional repression and effects of template methylation. J Biol Chem 268:19565-19573
43. Rhee I, Jair KW, Yen RW, Lengauer C, Herman JG, Kinzler KW, Vogelstein B, Baylin SB, Schuebel KE (2000) CpG methylation is maintained in human cancer cells lacking DNMT1. Nature 404:1003-1007
44. Melki JR, Vincent PC, Clark SJ (1999) Concurrent DNA hypermethylation of multiple genes in acute myeloid leukemia. Cancer Res 59:3730-3740
45. Rush LJ, Dai Z, Smiraglia DJ, Gao X, Wright FA, Fruhwald M, Costello JF, Held WA, Yu L, Krahe R et al. (2001) Novel methylation targets in de novo acute myeloid leukemia with prevalence of chromosome 11 loci. Blood 97:3226-3233
46. Belinsky SA, Nikula KJ, Palmisano WA, Michels R, Saccomanno G, Gabrielson E, Baylin SB, Herman JG (1998) Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis. Proc Natl Acad Sci USA 95:11891-11896
47. Stirzaker C, Millar DS, Paul CL, Warnecke PM, Harrison J, Vincent PC, Frommer M, Clark SJ (1997) Extensive DNA methylation spanning the Rb promoter in retinoblastoma tumors. Cancer Res 57:2229-2237
48. Millar DS, Ow KK, Paul CL, Russell PJ, Molloy PL, Clark SJ (1999) Detailed methylation analysis of the glutathione S-transferase Pi (GSTP1) gene in prostate cancer. Oncogene 18:1313-1324
49. Costello JF, Fruhwald MC, Smiraglia DJ, Rush LJ, Robertson GP, Gao X, Wright FA, Feramisco JD, Peltomaki P, Lang JC et al. (2000) Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat Genet 24:132-138
50. Herman JG, Civin CI, Issa JP, Collector MI, Sharkis SJ, Baylin SB (1997) Distinct patterns of inactivation of p15INK4B and p16INK4A characterize the major types of hematological malignancies. Cancer Res 57:837-841
51. Issa JP, Zehnbauer BA, Civin CI, Collector MI, Sharkis SJ, Davidson NE, Kaufmann SH, Baylin SB (1996) The estrogen receptor CpG island is methylated in most hematopoietic neoplasms. Cancer Res 56:973-977
52. Malinen T, Palotie A, Pakkala S, Peltonen L, Ruutu T, Jansson SE (1991) Acceleration of chronic myeloid leukemia correlates with calcitonin gene hypermethylation. Blood 77:2435-2440
53. Li Q, Kopecky KJ, Mohan A, Willman CL, Appelbaum FR, Weick JK, Issa JP (1999) Estrogen receptor methylation is associated with improved survival in adult acute myeloid leukemia. Clin Cancer Res 5:1077-1084
54. Costello JF, Plass C (2001) Methylation matters. J Med Genet 38:285-303
55. Melki JR, Vincent PC, Brown RD, Clark SJ (2000) Hypermethylation of E-cadherin in leukemia. Blood 95:3208-3213
56. Cameron EE, Baylin SB, Herman JG (1999) p15(INK4B) CpG island methylation in primary acute leukemia is heterogeneous and suggests density as a critical factor for transcriptional silencing. Blood 94:2445-2451
57. Song JZ, Stirzaker C, Harrison J, Melki JR, Clark SJ (2002) Hypermethylation trigger of the glutathione-S-transferase gene (GSTP1) in prostate cancer cells. Oncogene (in press)
58. Jones PL, Veenstra GJ, Wade PA, Vermaak D, Kass SU, Landsberger N, Strouboulis J, Wolffe AP (1998) Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet 19:187-191
59. Nan X, Ng HH, Johnson CA, Laherty CD, Turner BM, Eisenman RN, Bird A (1998) Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393:386-389
60. Bestor TH (1998) Gene silencing. Methylation meets acetylation. Nature 393:311-312
61. Cameron EE, Bachman KE, Myohanen S, Herman JG, Baylin SB (1999) Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat Genet 21:103-107
62. Lubbert M (2000) DNA methylation inhibitors in the treatment of leukemias, myelodysplastic syndromes and hemoglobinopathies: clinical results and possible mechanisms of action. Curr Top Microbiol Immunol 249:135-164
63. Jackson-Grusby L, Laird PW, Magge SN, Moeller BJ, Jaenisch R (1997) Mutagenicity of 5-aza-2′-deoxycytidine is mediated by the mammalian DNA methyltransferase. Proc Natl Acad Sci USA 94:4681-4685
64. Hanada M, Delia D, Aiello A, Stadtmauer E, Reed JC (1993) Bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia. Blood 82:1820-1828
65. Browett PJ, Norton JD (1989) Analysis of ras gene mutations and methylation state in human leukemias. Oncogene 4:1029-1036
66. Lubbert M, Miller CW, Koeffler HP (1991) Changes of DNA methylation and chromatin structure in the human myeloperoxidase gene during myeloid differentiation. Blood 78:345-356
67. Lubbert M, Oster W, Ludwig WD, Ganser A, Mertelsmann R, Herrmann F (1992) A switch toward demethylation is associated with the expression of myeloperoxidase in acute myeloblastic and promyelocytic leukemias. Blood 80:2066-2073
68. Watt PM, Kumar R, Kees UR (2000) Promoter demethylation accompanies reactivation of the HOX11 proto-oncogene in leukemia. Genes Chromosomes Cancer 29:371-377
69. Felgner J, Kreipe H, Heidorn K, Jaquet K, Zschunke F, Radzun HJ, Parwaresch MR (1991) Increased methylation of the c-fms protooncogene in acute myelomonocytic leukemias. Pathobiology 59:293-298
70. Zion M, Ben Yehuda D, Avraham A, Cohen O, Wetzler M, Melloul D, Ben Neriah Y (1994) Progressive de novo DNA methylation at the bcr-abl locus in the course of chronic myelogenous leukemia. Proc Natl Acad Sci USA 91:10722-10726
71. Nelkin BD, Przepiorka D, Burke PJ, Thomas ED, Baylin SB (1991) Abnormal methylation of the calcitonin gene marks progression of chronic myelogenous leukemia. Blood 77:2431-2434
72. Palotie A, Syvanen AC (1993) Development of molecular genetic methods for monitoring myeloid malignancies. Scand J Clin Lab Invest Suppl
73. Corn PG, Smith BD, Ruckdeschel ES, Douglas D, Baylin SB, Herman JG (2000) E-cadherin expression is silenced by 5′ CpG island methylation in acute leukemia. Clin Cancer Res 6:4243-4248
74. Issa JP, Zehnbauer BA, Kaufmann SH, Biel MA, Baylin SB (1997) HIC1 hypermethylation is a late event in hematopoietic neoplasms. Cancer Res 57:1678-1681
75. Melki JR, Vincent PC, Clark SJ (1999) Cancer-specific region of hypermethylation identified within the HIC1 putative tumour suppressor gene in acute myeloid leukaemia. Leukemia 13:877-883
76. Herman JG, Jen J, Merlo A, Baylin SB (1996) Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B. Cancer Res 56:722-727
77. Nguyen TT, Mohrbacher AF, Tsai YC, Groffen J, Heisterkamp N, Nichols PW, Yu MC, Lubbert M, Jones PA (2000) Quantitative measure of c-abl and p15 methylation in chronic myelogenous leukemia: biological implications. Blood 95:2990-2992
78. Chen W, Zhang W, Zhu J (1999) Homozygous deletion and methylation of p16 and p15 gene in acute leukemia. Zhonghua Xue Ye Xue Za Zhi 20:474-476
79. Guo SX, Taki T, Ohnishi H, Piao HY, Tabuchi K, Bessho F, Hanada R, Yanagisawa M, Hayashi Y (2000) Hypermethylation of p16 and p15 genes and RB protein expression in acute leukemia. Leuk Res 24:39-46
80. Liu M, Taketani T, Li R, Takita J, Taki T, Yang HW, Kawaguchi H, Ida K, Matsuo Y, Hayashi Y (2001) Loss of p73 gene expression in lymphoid leukemia cell lines is associated with hypermethylation. Leuk Res 25:441-447
81. Toyota M, Kopecky KJ, Toyota MO, Jair KW, Willman CL, Issa JP (2001) Methylation profiling in acute myeloid leukemia. Blood 97:2823-2829
82. Dottori M, Down M, Huttmann A, Fitzpatrick DR, Boyd AW (1999) Cloning and characterization of EphA3 (Hek) gene promoter: DNA methylation regulates expression in hematopoietic tumor cells. Blood 94:2477-2486
83. Tatarelli C, Linnenbach A, Mimori K, Croce CM (2000) Characterization of the human TESTIN gene localized in the FRA7G region at 7q31.2. Genomics 68:1-12